Study guide
10.1 Debridement Types, Indications, and Contraindications
WOCNCB Certified Wound Care Nurse CWCN
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current CWCN Exam Facts 1.2 Eligibility: Traditional, Experiential, and WTA-C Credit 1.3 Fees, Retakes, Recertification, and Test Strategy
2 Skin Biology, History & Systemic Factors
2.1 Integumentary Anatomy and Skin Barrier 2.2 Healing Phases, Healing vs Non-Healing, and Biofilm 2.3 History, Psychosocial Factors, Nutrition, and Pain 2.4 Systemic Healing Factors and Medications
3 Diagnostics and the Focused Wound Exam
3.1 Vascular, Laboratory, Imaging, and Perfusion Studies 3.2 Wound Measurement, Periwound Signs, and Dermatologic Differentials 3.3 When and How to Culture a Wound
4 Pressure Injury Pathophysiology and Staging
4.1 Pressure Injury Pathophysiology and Risk Tools 4.2 NPIAP Stages 1 through 4 4.3 Unstageable, DTPI, MDRPI, and Mucosal Injuries
5 Lower-Extremity and Special Etiologies
5.1 Venous / LEVD Ulcer Assessment 5.2 Arterial / LEAD Ulcer Assessment and PAD Testing 5.3 Neuropathic Foot Ulcers, Charcot, and Wagner Grading 5.4 Mixed Disease, Atypical, Surgical, Traumatic, and Burn Wounds
6 Prevention and Support Surfaces
6.1 Risk-Based Prevention: Moisture, Nutrition, Mobility, Cognition 6.2 Repositioning, Shear Reduction, and Seating 6.3 Support Surface Types and Selection
7 Offloading, Moisture, and Skin Products
7.1 Offloading and Protective Footwear 7.2 MASD/IAD, MARSI Prevention, and Skin Care Products 7.3 Friction, Heel Protection, and Preventing Treatment Complications
8 Wound-Care Principles, Pain, and Studies
8.1 Moisture Balance, Dead Space, and Periwound Protection 8.2 Recommending Pain Management Modalities 8.3 Obtaining Cultures and Recommending Studies
9 Cleansing and Wound Bed Preparation
9.1 Wound Cleansing Regimens 9.2 TIME: Infection, Moisture, and Edge Optimization 9.3 Chemical Cauterization Indications
10 Debridement Modalities
10.1 Debridement Types, Indications, and Contraindications 10.2 Conservative Sharp vs Surgical/Excisional Debridement 10.3 Autolytic, Enzymatic, Biological, and Mechanical Debridement
11 Topical Therapies
11.1 Hydrating Dressings: Hydrogels, Films, Hydrocolloids 11.2 Absorbent Dressings: Foams, Alginates, Hydrofibers 11.3 Antimicrobials, Odor Control, and Periwound Integrity
12 Compression Therapy
12.1 Compression Types, Indications, and Contraindications 12.2 Static vs Dynamic Compression Application 12.3 Mixed Arterial-Venous Disease and Compression Safety
13 Advanced and Adjunctive Therapies
13.1 Negative Pressure Wound Therapy 13.2 HBOT, Bioengineered Tissue, and Leech Therapy 13.3 Hydrotherapy, Pulsed Lavage, Mist, Maggot Therapy, and Total Contact Casting
14 Patient-Centered Goals
14.1 Patient-Centered Care, Access, and Cultural Beliefs 14.2 Preventive, Palliative, Maintenance, and Curative Goals 14.3 Writing Patient-Focused Skin and Wound Goals
15 Evaluation, Modification, and Documentation
15.1 Evaluating Treatment Effectiveness 15.2 Interpreting Response and Modifying the Plan 15.3 Documentation, CMS Quality Context, and Surveillance
16 Patient and Caregiver Education
16.1 Health Literacy, Goals, and Teach-Back 16.2 Educating on Procedures, Skin Care, and Diagnostic Results 16.3 Modifiable Risk Factors and Resource Access
17 Educating Other Clinicians
17.1 Teaching Skin and Wound Principles, Procedures, and Goals 17.2 Infection Control, Repositioning, Moisture, Nutrition, and Trauma Avoidance for Teams 17.3 Recommending Non-Invasive and Invasive Next Steps
18 Collaboration, Referral, and Handoff
18.1 Support, Supply Access, Post-Acute Care, and Service Referrals 18.2 Referring for Studies and Specialty Consults 18.3 Handoff Communication Across Settings
10.1 Debridement Types, Indications, and Contraindications
Key Takeaways Explain This Topic AI
Debride necrotic tissue when the wound is healable and perfusion is adequate; cleansing lifts debris, debridement removes adherent nonviable tissue.
Six modality families are biologic/maggot, autolytic, chemical/enzymatic, mechanical, surgical/excisional, and conservative sharp; match tissue, pain, setting, RN scope, and speed.
Keep dry, stable, noninfected eschar on an ischemic heel or limb as a physiologic dressing; do not wet, enzyme, or pick it just to assign a stage.
Do not debride pyoderma gangrenosum for pathergy without a specialist plan, and do not aggressively debride malignant wounds unless directed.
Clotting disorders and anticoagulation are relative limits on sharp methods, not a ban on autolytic or enzymatic debridement.
Last updated: September 2026
Debridement Types, Indications, and Contraindications
Quick Answer: Debride necrotic tissue when the wound is healable and perfusion is adequate . The six modality families are biologic/maggot, autolytic, chemical/enzymatic, mechanical, surgical/excisional, and conservative sharp. Keep dry, stable eschar on an ischemic heel or limb as a physiologic dressing unless infection appears. Do not debride pyoderma gangrenosum for pathergy without a specialist plan, do not aggressively debride malignant wounds unless directed, and treat clotting disorders or anticoagulation as relative limits on sharp work. Pick the method by tissue type, pain, setting, RN scope, and how fast the bed must be cleaned.
The CWCN Treatment outline lists types of debridement ( 030201 ) and identifying indications and contraindications for debridement ( 030202 ) as separate items. Domain II ( Intervention ) samples the same ground from the intervention side— types, indications, and contraindications of debridement ( 020104 )—so you must judge both whether tissue needs removal and whether the wound can tolerate that removal. Independent ExamFinch teaching uses those outline numbers as a study map. This chapter is not a WOCNCB product and does not claim Board endorsement.
Debridement is the T in TIME (Chapter 9): remove slough, eschar, biofilm, and senescent cells so keratinocytes can migrate. Cleansing lifts what is already loose. Debridement takes what is adherent and nonviable . Leaving a coat of necrosis on a healable wound is not gentle care. It is a bioburden reservoir, a barrier to measurement, and a reason serial visits look unchanged.
Healable first, then method
A method is only as safe as the goal . A practical gate used in wound practice is healable versus maintenance versus nonhealable:
Healable: adequate blood flow, the cause is being treated, and the host can close the wound. Necrotic tissue should come off.
Maintenance: healing is possible in theory, but resources, adherence, or access stall progress. Debride enough to control odor and infection risk; do not chase closure with daily heroic sharp work the patient cannot support.
Nonhealable / palliative: ischemia, a dying host, or a wound that will not close. Keep dry stable eschar closed. Debride only if infection, odor, or bulk is harming comfort.
Exam stems punish the mismatch: wet autolysis on a dry ischemic heel, or refusal to remove loose slough from a well-perfused sacral Stage 3.
Perfusion is not a guess. Use pulses, capillary refill, ankle-brachial index (ABI) or toe-brachial index (TBI) when vessels are calcified, and the ischemic story (claudication, rest pain, dependent rubor, a cool pale foot). An ABI too low to support healing is a reason to keep dry eschar closed , not a reason to freshen it with hydrogel.
Six modality families
Family Mechanism Typical speed Selectivity
Autolytic Host enzymes and neutrophils liquefy necrosis under a moisture-retentive dressing (hydrogel, hydrocolloid, transparent film, medical honey) Days to weeks Selective for nonviable tissue if the dressing stays moist and the host is competent
Chemical / enzymatic Exogenous enzyme—most often Clostridium collagenase ointment—cleaves collagen that anchors necrosis Days Relatively selective for collagen-containing necrosis
Biologic / maggot Medicinal larvae of Lucilia sericata secrete enzymes and ingest slough Hours to a few days per application Highly selective; larvae prefer necrotic tissue when used as directed
Mechanical Physical force: wet-to-dry gauze, whirlpool, pulsed lavage, monofilament fiber pads, low-frequency ultrasound Minutes to one dressing cycle Often nonselective (wet-to-dry, whirlpool); some pads and ultrasound are more targeted
Conservative sharp (CSD) Sequential bedside removal of loose necrotic tissue with scalpel, scissors, or curette by a competent RN within scope and privilege Minutes Selective if you stop at viable tissue
Surgical / excisional Operating-room or procedure-room removal of extensive necrosis, often to bleeding viable tissue, with anesthesia and hemostasis resources One session for a large burden May include a margin of viable tissue for source control
Older texts used chemical debridement for hypochlorite soaks that loosen necrosis. On current items, enzymatic almost always means collagenase. Chemical cauterization with silver nitrate (Chapter 9, task 030203) is a different job: flattening hypergranulation or stopping capillary ooze, not digesting a slab of eschar.
Indications: necrosis on a healable, perfused wound
Debride when you see nonviable tissue —yellow, gray, or tan slough; black or brown eschar; or a biofilm film that will not irrigate off— and the wound is intended to heal and arterial inflow can support the tissue you will expose.
Other indication clusters:
Infection under or in necrosis: fluctuance, spreading erythema, purulence, or odor with systemic signs can convert a leave-it eschar into an urgent removal problem, often surgical.
Need to see the base: an unstageable pressure injury on a healable, well-perfused sacrum will not be accurately staged or treated until obscuring tissue is gone.
Odor, bulk, and drainage that impair dignity or dressing seal on a maintenance wound—limited debridement for quality of life, not a closure fantasy.
Biofilm is an indication for serial debridement, not a single scrape. Combine removal with cleansing and a time-limited antimicrobial plan rather than rotating dressings while the film stays put.
Contraindications you must not blur
Dry, stable eschar on an ischemic heel or limb. Firm, dry, adherent, nonfluctuant black plaque without surrounding cellulitis is a physiologic dressing . Keep it dry, offload it, and watch. Wetting it for autolysis, painting enzyme on it, or picking it with a scalpel can open a wound that cannot granulate. Infection—fluctuance, drainage, advancing erythema, fever—changes the rule: then the cap comes off, often in a surgical setting.
Pyoderma gangrenosum (PG) and pathergy. PG ulcers enlarge after trauma. Sharp, mechanical, or aggressive enzymatic debridement without a dermatology or wound-specialist plan can double the wound overnight. Pain out of proportion, undermined violaceous borders, and rapid expansion after a cleanup are the stem. Immunosuppression treats the disease; debridement is not the first reflex.
Malignant wounds (fungating tumors, cutaneous metastases) unless a specialist directs limited cleanup. Aggressive debridement can bleed and does not treat the cancer. Goals are odor, exudate, and comfort.
Clotting disorders and anticoagulation are relative contraindications for sharp methods. Autolytic or enzymatic approaches may still be appropriate. For CSD, know the INR, PTT, and platelet story, hold what the prescriber allows, have hemostasis ready, and refer if the tissue is vascular or the coagulopathy is uncontrolled. Do not treat on warfarin as an absolute ban on every form of debridement.
Other stop signs: wounds over uncontrolled bleeding , wounds sitting on a major vessel or graft until a surgeon is in the plan, and the clinician who lacks competency, privilege, or lighting .
How to choose the modality
Match five filters, not a favorite product:
Tissue: loose slough versus leather eschar versus infected wet necrosis versus biofilm film. Loose tissue can be CSD. Leathery eschar on a healable wound may need scoring plus enzyme or surgical excision. Infected wet necrosis often needs surgical speed.
Pain: wet-to-dry and whirlpool hurt. Autolytic and enzymatic are slower and usually kinder. Premedicate before CSD (Chapter 8).
Setting: home care may lack sterile sharp trays or maggot logistics. Operating-room time is scarce.
RN scope and facility privilege: CSD is not a hobby. If your license and policy do not cover it, recommend it and arrange who will do it.
Speed needed: spreading infection and necrotizing soft-tissue infection are not hydrogel problems. A stalled but uninfected venous ulcer can wait for autolysis.
Scenario: two heels, two answers
Ms. Cole, 81, has a dry, black, firmly adherent left-heel plaque, nonpalpable pulses, no fluctuance, and an ABI of 0.42. The floor wants it opened so it can be staged. Independent ExamFinch teaching is to leave the stable ischemic eschar , offload, keep it dry, and obtain vascular input. Staging remains unstageable while the base is hidden.
Her roommate, Mr. Diaz, has a well-perfused sacral pressure injury with a 1 cm ring of loose yellow slough, palpable pulses, and no spreading cellulitis. Here necrosis is an indication. Choose a modality he can tolerate in this setting—often CSD of the loose tissue plus a moisture-retentive dressing for remaining film, or enzyme if sharp is not privileged that visit. Do not copy the heel plan onto the sacrum.
Facility policy, product labels, and the current WOCNCB CWCN detailed content outline remain the source of record for what items can sample. ExamFinch teaches the clinical gate: healable and perfused before you pick a tool .